Similar articles

• Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.

  Brambilla E, Moro D, Gazzeri S, Brambilla C. Brambilla E, et al. J Pathol. 1999 Aug;188(4):351-60. doi: 10.1002/(SICI)1096-9896(199908)188:4<351::AID-PATH385>3.0.CO;2-W. J Pathol. 1999. PMID: 10440744
• Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.

  Mohamed S, Yasufuku K, Hiroshima K, Nakajima T, Yoshida S, Suzuki M, Sekine Y, Shibuya K, Iizasa T, Farouk A, Fujisawa T. Mohamed S, et al. Cancer. 2007 Jun 15;109(12):2506-14. doi: 10.1002/cncr.22651. Cancer. 2007. PMID: 17487846
• Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer.

  Peters MG, Vidal Mdel C, Giménez L, Mauro L, Armanasco E, Cresta C, Bal de Kier Joffé E, Puricelli L. Peters MG, et al. Oncol Rep. 2004 Nov;12(5):1143-50. Oncol Rep. 2004. PMID: 15492807
• Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.

  Krecicki T, Smigiel R, Fraczek M, Kowalczyk M, Sasiadek MM. Krecicki T, et al. J Laryngol Otol. 2004 Sep;118(9):676-80. doi: 10.1258/0022215042244769. J Laryngol Otol. 2004. PMID: 15509364
• Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.

  Brambilla E, Gazzeri S, Moro D, Lantuejoul S, Veyrenc S, Brambilla C. Brambilla E, et al. Clin Cancer Res. 1999 Feb;5(2):243-50. Clin Cancer Res. 1999. PMID: 10037171